In the neurological disease overlay, CST3 was associated with area of amyloid-beta plaques, early onset Alzheimer’s disease, progressive cognitive impairment, and loss of hippocampal neurons (Figure 9). This evidence concerns the gene CST3 and Alzheimer disease.